Sayem Ahmed: School of Health and Wellbeing, University of Glasgow, UK
Dr Ahmed is a Research Associate at the Health Economics and Health Technology Assessment (HEHTA) research group, University of Glasgow. His research deals with estimating health economic burden and economic evaluation of interventions targeting infectious diseases especially neglected tropical and vaccine-preventable ones. In addition, Sayem conducted research on health insurance, healthcare financing, financial risk protection for universal health coverage and health systems efficiency in low and middle-income countries. He is currently working on several research studies at HEHTA undertaking economic evaluations alongside clinical trials.
Saskia den Boon: World Health Organization, Switzerland
Saskia den Boon is a technical officer in the Global Tuberculosis Programme of WHO, where she works on TB screening and prevention as well as research and innovation. She previously worked as a consultant for the WHO Department of Immunizations, Vaccines and Biologicals where she was involved in economical evaluations of vaccine programs. Saskia holds a MSc in Health Economics, Policy and Management from LSE, and a PhD in tuberculosis epidemiology from the University of Amsterdam.
Edris Hasanpoor: Maragheh University of Medical Sciences, Iran
Edris Hasanpoor got his Ph.D., in Healthcare Management, Fellowship of Evidence-Based Medicine from Joanna Briggs Institute (JBI) affiliated to Adelaide University of Australia. He is an Assistant Professor at Maragheh University of Medical Sciences. He is responsible for the establishment of the Research Center for Evidence-Based Health Management in Maragheh. Dr. Hasanpoor's research focuses on three important problems in healthcare: non-evidence based decisions in healthcare, overuse in medical care and poor medical communication.
Abdur Razzaque Sarker: Bangladesh Institute of Development Studies, Bangladesh
Dr Abdur Razzaque Sarker is a Health Economist working at the Bangladesh Institute of Development Studies (BIDS). He is a trained researcher and has worked in health systems and economic analysis in developed and developing nations. Earlier, he worked as a Health Economist Researcher at the University of Birmingham, Mahidol Oxford Tropical Medicine Research Unit, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). Dr Sarker AR obtained his Ph.D. from the University of Strathclyde, United Kingdom, and completed his 'Master of Health Economics' and 'Master of Economics' from Bangladesh. His research focuses on health economics issues, particularly economic analysis from various perspectives, economic evaluation of public health programs, including the economics of vaccine-preventable diseases, the economics of non-communicable diseases, quality of life research, and healthcare financing issues and immunization economics.